Glaucoma Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Global Glaucoma Therapeutics Market was USD 6.59 billion in 2020 and is anticipated to exhibit a CAGR of 6% during the forecast period 2021-2027.

Glaucoma treatment represents a variety of treatment alternatives for primary angle of open (POA) and primary angle of closure (PAC) glaucoma. The disease is characterized by structural changes in the optic nerve, usually leading to vision loss and blindness. Glaucoma treatment can be started with topical eye drops, which consist mainly of beta blockers, prostaglandin analogs, cholinergic, carbonic anhydrase inhibitors, and alpha-adrenergic agonists. These eye drops reduce intraocular pressure (IOP) by minimizing the production of fluid in the eye. This can be followed by traditional or laser surgical procedures, or a combination of the two, using products such as implantable sustained release devices, polymer-based contact lenses, drug-eluting punctal plugs, microneedle injection devices, and micro-dosage technologies.

Market Segmentation:

By Disease Type

• Primary Open Angle Glaucoma (POAG)
• Primary Angle Closure Glaucoma (PACG)

By Drug Class:

• Alpha adrenergic Agonist
• Beta Blockers
• Prostaglandin Analogs
• Carbonic Anhydrase Inhibitor
• Cholinergic
• Combined Medication
• Fixed-dose Combinations

Key Players

• Merck & Co., Inc. (U.S.)
• Novartis AG (Switzerland)
• Allergan plc (part of AbbVie Inc.) (Ireland)
• Bausch and Lomb Incorporated (U.S.)
• Teva Pharmaceuticals Industry (Israel)
• Pfizer, Inc. (U.S.)
• Aerie Pharmaceuticals (U.S.)
• Inotek Pharmaceuticals (U.S.)

Scope of the Report

The research study analyzes the global Glaucoma Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Glaucoma Therapeutics Market Report

1. What was the Glaucoma Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Glaucoma Therapeutics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Glaucoma Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.